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Schiff baseAbstract Eighteen structurally-related Schiff base derivatives, which belong to salicylidenebenzylamine
and 2-hydroxy-1-naphthylidenebenzylamine families were prepared and characterized by spectroscopic
techniques. All the synthesized compounds were screened in vitro for their antibacterial and antifungal
activities. Human pathogenic gram-negative (Escherichia coli, Proteus mirabilis, Pseudomonas aeruginosa
and Serratia marcescens), gram-positive bacteria (Staphylococcus epidermidis, Staphylococcus aureus and
Bacillus subtilis), and fungi (Alternaria alternata,Aspergillus niger,Penicillium roqueforti, andSaccharomy-
ces cerevisiae)were evaluated based on their toxicity to different concentrations of Schiff base compounds.
Forassessmentof toxicity topathogens, adisc diffusionassaywasused to test the antimicrobial properties.
The results revealed some antimicrobial activities of some of the synthesized compounds. Among the
tested pathogens, the synthesized salicylidinaniline derivatives show highly potent action towards Alter-
naria alternata. Interestingly, a compoundwhich contains the –Cl group is only effective against gramneg-
ative bacteria, but not gram positive bacteria. No remarkable antibacterial or antifungal activities were
observed in the presence of –CH3 or –Br group. Furthermore, most of the naphthalene-containing com-
pounds show no growth retardation towards bacterial or fungal pathogens. On the other hand, the pres-
ence of –OH or –SH group at para or ortho position, respectively, on the aniline site is correlated with an
increased inhibitory drug effect on all pathogens. The importance of our ﬁndings to the drug research and
developments is discussed in the context of ﬁnding a correlation between the structural properties of
the new drugs and their biological activities.
ª 2013 Production and hosting by Elsevier B.V. on behalf of King Saud University.
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Schiff bases play an important role in biological systems with
several applications. They act as anticancer (Desai et al., 2001;
Przybylski et al., 2008; Sinha et al., 2008), antibacterial (Abdel
Aziz et al., 2012; Al-Kahraman et al., 2010; Amin et al., 2010;
Karthikeyan et al., 2006; Przybylski et al., 2009; Ronad et al.,
2010; Vukovic et al., 2010), antifungal (Al-Kahraman et al.,
2010; Panneerselvam et al., 2005; Saravanan et al., 2010;
Vukovic et al., 2010), antiviral (Jarrahpour et al., 2007), anti-
parasitic agents (Al-Kahraman et al., 2010) in addition to
other biological performances (Odabasoglu et al., 2007; Vicini
et al., 2003). In particular, the interest on Schiff base deriva-
tives, which belong to the salicylidenebenzylamine (SA) family
has been renewed very recently by some medicinal chemists
due to their known antimicrobial, antifungal and antitumor
activities (Abdel Aziz et al., 2012; Al-Kahraman et al., 2010;
Kumar et al., 2010; Nair et al., 2002; Unver et al., 2005). Some
of these derivatives were also used as starting materials to pre-
pare the ﬁnal therapeutic products (Guo et al., 2011; Tang
et al., 2011).
Of relevant studies, the applications of SA-based Schiff
base derivatives in cellular imaging, as well as building units
in constructing sensing assemblies have also been published re-
cently (Kim et al., 2012a,b; Singh et al., 2008). Not to mention,
2-hydroxy Schiff base derivatives have been characterized in
many occasions as molecular switches due to the keto-enol
tautomeric equilibrium, which they exhibit in solid state and
in solution (Fita et al., 2005; Ohshima et al., 2004; Salman
and Saleh, 1997a,b, 1998; Sauer et al., 2006). Generally, Schiff
base ligands were prepared in several forms of acyclic and
macrocyclic through convenient and straightforward synthetic
methods with the prospective of understanding the structural
effects on the recognition behaviours of the designed molecules
(Sreenivasolu, 2012).
The intermolecular recognitions form the basis for the most
impressive functions of living systems and life science (Sreeni-
vasolu, 2012). Along with this line, the prediction of the abso-
lute biological signals for potential molecule on the basis of
their speciﬁc structures appears to be important to the ongoing
drug researches and developments (Bajorath, 2012; Saleh et al.,
2011). Therefore, the antibacterial and antifungal tests in the
present work were conducted on a series of Schiff base SA
compounds and other 2-hydroxy Schiff base derivatives, which
share common structural features in order to gain more in-
sights on the exact relationship between their speciﬁc chemical
structures and the absolute biological data.
As shown in Fig. 1, the proposed SA and the other 2-hydro-
xy Schiff base compounds differ only by the presence/absence
of one phenyl/pyridine ring on the aldehyde/amine sites. Addi-
tionally, several potential substituents were introduced to the
ortho and para position of the aniline or aryl site of the SA
derivatives. The rationale behind this selection stems from
the fact that by adding an aromatic ring, one expects an in-
crease in the lipophilicity of the drug, which should enhance
its penetration into the bacterial/fungal cell membrane. In
addition, ligation of such aromatic ring should decrease the
basicity of the examined drug, thus suppressing its binding
with acidic DNA molecule. The long-term goal is to advance
our understanding towards the establishment of reliable struc-
ture–activity relationship.2. Experimental
2.1. Materials
Compounds 1–18 (Fig. 1) were obtained by the condensation
of salicylaldehyde or 2-hydroxynaphthaldehyde with the
appropriate commercial aromatic amines in reﬂuxing ethanol
(Scheme 1). The crude products were recrystallized from etha-
nol and characterized by spectroscopic methods. All the prod-
ucts are known and show characteristic infrared (IR)
stretching frequency for the imine (KBr disc) between 1614
and 1620 cm1 and a peak at d= 8.9 ppm in the 1H NMR
corresponding to imine = CH proton (Abdel-Latif et al.,
2007; Bennett et al., 2009; Dal et al., 2007; Ligtenbarg et al.,
1999; Ghedini et al., 1991; Goetz, 1968; Guo et al., 2011; Jain
and Sain, 2008; Karakas et al., 2004; Kumar et al., 2010;
Makal et al., 2011; Ohshima et al., 2004; Ozha et al., 1974;
Sanchez et al., 2002; Singh et al., 2008; Tisato et al., 1990).
Reagent grade chemicals and solvents were purchased
from Sigma Aldrich and were used without further puriﬁca-
tion. Melting points were determined on a Stuart Scientiﬁc
melting point apparatus model SMP 10 and are uncorrected.
IR spectra were recorded on a KBr disc. The NMR spectra
were recorded on a Varian instrument at 400 and 100 MHz
for 1H NMR and 13C NMR spectra, respectively. The pro-
ton chemical shifts were reported in parts per million (d
ppm) and coupling constants (J) in Hertz (Hz) and s, d, t,
m, br s refer to singlet, doublet, triplet, multiplet and broad,
respectively.
2.1.1. 2-((E)-(Phenylimino)methyl)phenol (1)
A stirred mixture of salicylaldehyde (1.22 g, 10 mmol) and ani-
line (837 mg, 9 mmol) in bench ethanol (10 mL) was reﬂuxed
for 3 h. The mixture was cooled in an ice-bath and the result-
ing yellow crystals were ﬁltered, washed with cold ethanol and
dried under vacuo to give 1. Yield: 650 mg (37%); mp: 44–
45 C; 1H NMR (400 MHz, DMSO-d6): d= 6.92–6.97 (m,
2H), 7.25–7.30 (m, 1H), 7.36–7.45 (m, 5H), 7.61–7.64 (m,
1H), 8.91 (s, 1H), 13.15 (s, 1H); 13C NMR (100 MHz,
DMSO-d6): d= 117.0, 119.5, 119.7, 121.8, 127.4, 129.9,
133.1, 133.7, 148.5, 160.8, 163.9.2.1.2. 2-((E)-(4-Chlorophenylimino)methyl)phenol (2)
Compound 2 was prepared from salicylaldehyde (1.22 g,
10 mmol) and 4-chloroaniline (1.15 g, 9 mmol); Yield: 1.38 g
(66%); mp: 101–102 C; 1H NMR (400 MHz, DMSO-d6):
d= 6.93–6.96 (m, 2H), 7.36–7.47 (m, 5H), 7.60–7.63 (m,
1H), 8.90 (s, 1H), 12.82 (s, 1H); 13C NMR (100 MHz,
DMSO-d6): d 117.0, 119.6, 119.7, 123.6, 129.8, 131.6, 133.0,
133.9, 147.4, 160.7, 164.4.2.1.3. 2-((E)-(4-Bromophenylimino)methyl)phenol (3)
Compound 3 was prepared from salicylaldehyde (1.22 g,
10 mmol) and 4-bromoroaniline (1.55 g, 9 mmol); Yield:
1.69 g (68%); mp: 110–112 C; 1H NMR (400 MHz, DMSO-
d6): d= 6.93–6.97 (m, 2H), 7.32–7.42 (m, 3H), 7.58–7.64 (m,
3H), 8.91 (s, 1H), 12.78 (s, 1H); 13C NMR (100 MHz,
DMSO-d6): d 117.1, 119.7, 120.0, 124.0, 132.7, 133.0, 134.0,
147.9, 160.7, 164.4.
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Figure 1 The chemical structures of the examined structurally-related Schiff base derivatives.
830 S. Hisaindee et al.2.1.4. (E)-4-(2-Hydroxybenzylideneamino)benzenesulfonamide
(4)
Compound 4 was prepared from salicylaldehyde (1.22 g,
10 mmol) and 4-aminosulfonamide (1.40 g, 9 mmol); Yield:
0.54 g (23%); 1H NMR (400 MHz, DMSO-d6): d= 6.95–
7.00 (m, 2H), 7.39–7.45 (m, 2H), 7.52–7.55 (m, 2H), 7.68
(dd, JAB = 7.6 Hz, JAX = 2.0 Hz, 1H); 7.85–7.87 (m, 2H),
8.97 (s, 1H), 12.62 (s br, 1H); 13C NMR (100 MHz, DMSO-d6): d= 117.1, 119.7, 122.2, 127.5, 133.1, 134.3, 142.4, 151.6,
160.7, 165.5.
2.1.5. 2-((E)-(2-Hydroxybenzylideneamino)methyl)benzoic
acid (5)
Compound 5 was prepared from salicylaldehyde (1.22 g,
10 mmol) and 4-aminobenzoic acid (1.23 g, 9 mmol);
Yield: 1.62 g (74%); 1H NMR (400 MHz, DMSO-d6):
OH
CHO
OH
N
Ar
Scheme 1 Reaction conditions: ArNH2, EtOH, reﬂux 3 h.
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7.97–8.00 (m, 2H), 8.96 (s, 1H), 12.65 (s br, 1H), 12.90 (s br,
1H); 13C NMR (100 MHz, DMSO-d6): d 117.1, 119.8, 122.0,
129.2, 131.2, 133.1, 134.3, 152.6, 160.8, 165.2, 167.3.
2.1.6. 2-((E)-(2-Hydroxyphenylimino)methyl)phenol (6)
Compound 6 was prepared from salicylaldehyde (1.22 g,
10 mmol) and 2-aminophenol (982 mg, 9 mmol); Yield:
1.63 g (85%); 1H NMR (400 MHz, DMSO-d6): d= 6.83–
6.97 (m, 4H), 7.06–7.13 (m, 1H), 7.32–7.38 (m, 2H), 7.58
(dd, JAB = 8.0 Hz, JAX = 1.6 Hz, 1H), 8.94 (s, 1H), 9.72 (s
br, 1H), 13.80 (s br, 1H); 13C NMR (100 MHz, DMSO-d6):
d 117.0, 117.1, 119.1, 119.9, 120.03, 120.06, 128.5, 132.8,
133.3, 135.4, 151.6, 161.2, 162.1.
2.1.7. 2-((E)-(p-Tolylimino)methyl)phenol (7)
Compound 7 was prepared from salicylaldehyde (1.22 g,
10 mmol) and 4-methylaniline (965 mg, 9 mmol); Yield:
1.38 g (72%); mp: 95–96 C; 1H NMR (400 MHz, DMSO-
d6): d= 2.24 (s, 3H), 6.91–6.95 (m, 2H), 7.19–7.21 (m, 2H),
7.26–7.29 (m, 2H), 7.37 (dd, JAB = 15.6 Hz, JAX = 2.0 Hz,
1H), 7.36–7.37 (m, 1H), 7.59 (dd, JAB = 8.0 Hz, JAX = 2 Hz,
1H), 8.89 (s, 1H), 13.2 (s br, 1H); 13C NMR (100 MHz,
DMSO-d6): d 21.0, 117.0, 119.5, 119.7, 121.6, 130.3, 132.9,
133.4, 136.9, 145.8, 160.8, 162.9.
2.1.8. 2-((E)-(5-Methylpyridin-2-ylimino)methyl)phenol (8)
Compound 8 was prepared from salicylaldehyde (732 mg,
6 mmol) and 5-methyl-2-aminopyridine (540 mg, 5 mmol);
Yield: 730 mg (69%); mp: 104–105 C; 1H NMR (400 MHz,
DMSO-d6): d= 2.24 (s, 3H), 6.90–6.96 (m, 2H), 7.22–7.28
(m, 1H), 7.34–7.42 (m, 1H), 7.60–7.69 (m, 2H), 8.28 (s, 1H),
9.40 (s, 1H), 13.16 (s, 1H); 13C NMR (100 MHz, DMSO-d6):
d= 17.9, 117.1, 119.4, 119.63, 119.68, 132.8, 133.6, 134.1,
139.5, 149.4, 155.5, 161.3, 163.9.
2.1.9. 2-((E)-(Naphthalen-1-ylimino)methyl)phenol (9)
Compound 9 was prepared from salicylaldehyde (1.22 g,
10 mmol) and 1-naphthaldehyde (1.41 g, 9 mmol); Yield:
1.29 g (53%); 1H NMR (400 MHz, DMSO-d6): d=
6.96–7.04 (m, 2H), 7.36–7.56 (m, 2H), 7.50–7.58 (m, 3H),
7.70–7.73 (m, 1H), 7.82–7.85 (m, 1H), 7.93–7.94 (m, 1H),
8.14–8.17 (m, 1H), 8.97 (s, 1H), 13.1 (s br, 1H); 13C NMR
(100 MHz, DMSO-d6): d= 114.9, 117.1, 119.7, 120.2, 122.9,
126.7, 127.0, 127.1, 128.2, 128.4, 132.9, 133.9, 134.0, 146.0,
160.80, 160.81, 164.5.
2.1.10. 1-((E)-(Phenylimino)methyl)naphthalen-2-ol (10)
Compound 10 was prepared from 2-hydroxynaphthaldehyde
(1.72 g, 10 mmol) and aniline (837 mg, 9 mmol); Yield: 1.59 g(67%); 1H NMR (400 MHz, DMSO-d6): d= 6.96 (d,
J= 9.2 Hz, 1H), 7.27–7.33 (m, 2H), 7.45–7.53 (m, 3H), 7.61
(d, J= 8.0 Hz, 1H), 7.75 (d, J= 8.0 Hz, 1H), 7.89 (d,
J= 9.2 Hz, 1H), 8.45 (d, J= 8.4 Hz, 1H), 9.62 (s, 1H); 13C
NMR (100 MHz, DMSO-d6): d= 108.9, 120.7, 120.8, 122.8,
123.9, 126.9, 127.0, 128.6, 129.5, 130.1, 133.7, 137.5, 144.0,
155.7, 171.6.
2.1.11. 1-((E)-(Naphthalen-1-ylimino)methyl)naphthalen-2-ol
(11)
Compound 11 was prepared from 2-hydroxynaphthaldehyde
(1.72 g, 10 mmol) and 1-napthylmine (1.29 g, 9 mmol); Yield:
1.68 g (63%); 1H NMR (400 MHz, DMSO-d6): d= 7.13 (d,
J= 9.2 Hz, 1H), 7.34–7.38 (m, 1H), 7.53–7.68 (m, 4H),
7.81–7.84 (m, 2H), 7.88 (d, J= 8.0 Hz, 1H), 7.97–8.01 (m,
2H), 8.22 (d, J= 8.4 Hz, 1H), 8.55 (d, J= 8.8 Hz, 1H), 9.80
(s, 1H); 13C NMR (100 MHz, DMSO-d6): d= 109.8, 115.5,
121.0, 121.7, 122.2, 124.1, 126.8, 127.0, 127.1, 127.3, 127.4,
127.46, 128.6, 128.8, 129.5, 133.4, 134.1, 137.1, 142.3, 158.3,
168.8.
2.1.12. 2-(E)-(Quinolin-8-ylimino)methyl)phenol (12)
Compound 12 was prepared from salicylaldehyde (0.67 g,
5.5 mmol) and 8-aminoquinoline (0.70 g, 5 mmol); Yield:
1.01 g (81%). 1H NMR (400 MHz, CDCl3): d= 6.94 (t,
J= 7.9 Hz, 1H), 7.07 (d, J= 7.9 Hz, 1H), 7.39 (t,
J= 7.9 Hz, 1H), 7.43 (d, J= 7.9 Hz, 1H), 7.44 (dd, J= 8.3,
4.2 Hz, 1H), 7.49 (d, J= 8.1 Hz, 1H), 7.57 (t, J= 8.1 Hz,
1H), 7.72 (d, J= 8.1 Hz, 1H), 8.18 (dd, J= 8.3, 1.7 Hz, 1H),
8.92 (s, 1H), 8.97 (dd, J= 4.2, 1.7 Hz, 1H), 12.64 (s br, 1H).
2.1.13. (6Z)-6-((Quinolin-8-ylamino)methylene)cyclohexa-
2,4-dienone (13)
Compound 13 was prepared from 2-hydroxynaphthaldehyde
(1.72 g, 10 mmol) and 8-aminoquinoline (1.30 g, 9 mmol);
Yield: 2.23 g (83%); 1H NMR (400 MHz, DMSO-d6):
d= 6.70 (d, J= 9.6 Hz, 1H), 7.24–7.27 (m, 1H), 7.46–7.50
(m, 1H), 7.63–7.85 (m, 3H), 8.41–8.47 (m, 3H), 9.01–9.03 (m,
1H), 9.59 (d, J= 11.6 Hz, 1H); 13C NMR (100 MHz,
DMSO-d6): d= 108.7, 115.1, 120.4, 123.0, 123.9, 124.9,
126.7, 127.4, 128.8, 128.9, 129.6, 134.7, 136.8, 136.9, 139.2,
139.8, 147.8, 150.6, 181.7.
2.1.14. 2-((E)-(2-Mercaptophenylimino)methyl)phenol (14)
Compound 14 was prepared from salicylaldehyde (1.22 g,
10 mmol) and 2-aminothiophenol (1.13 g, 9 mmol); Yield:
1.90 g (92%); 1H NMR (400 MHz, DMSO-d6): d= 6.49 (d,
J= 2.4 Hz, 1H), 6.53–6.57 (m, 1H), 6.66 (d, J= 7.6 Hz,
1H), 6.75–6.87 (m, 4H), 6.93 (d, J= 7.6 Hz, 1H), 7.06–7.11
832 S. Hisaindee et al.(m, 1H), 7.39 (d, J= 6.4 Hz, 1H), 9.89 (s, 1H); 13C NMR
(100 MHz, DMSO-d6): d= 109.0, 115.3, 118.9, 119.2, 121.6,
125.6, 126.3, 129.0, 130.0, 148.3, 153.9.
2.1.15. (E)-2-(Hydroxybenzylideneamino)benzoic acid (15)
Compound 15 was prepared from salicylaldehyde (1.22 g,
10 mmol) and 2-aminobenzoic acid (1.23 g, 9 mmol); Yield:
1.42 g (65%); 1H NMR (400 MHz, DMSO-d6): d= 6.91–
6.96 (m, 2H), 7.30–7.45 (m, 3H), 7.62–7.60 (m, 2H), 7.84 (d,
J= 6.8 Hz, 1H), 8.83 (s br, 1H), 13.00 (s br, 2H); 13C NMR
(100 MHz, DMSO-d6): d= 110.0, 115.0, 116.7, 117.6, 119.5,
119.9, 122.7, 129.7, 131.6, 134.2, 136.8, 151.9, 161.2, 170.0.
2.1.16. 2-((E)-(4-Hydroxyphenylimino)methyl)phenol (16)
Compound 16 was prepared from salicylaldehyde (1.22 g,
10 mmol) and 4-hydroxyphenol (982 mg, 9 mmol); Yield:
0.72 g (37%); mp; 135–137 C; 1H NMR (400 MHz, DMSO-
d6): d= 6.80–6.94 (m, 4H), 7.28–7.36 (m, 3H), 7.54–7.56 (m,
1H), 8.86 (s, 1H), 9.66 (s br, 1H), 13.4 (s br, 1H); 13C NMR
(100 MHz, DMSO-d6): d= 116.4, 116.9, 119.4, 119.9, 123.1,
132.6, 132.9, 139.6, 157.4, 160.6.
2.1.17. 2-((E)-(4-Mercaptophenylimino)methyl)phenol (17)
Compound 17 was prepared from salicylaldehyde (256 mg,
2.1 mmol) and 4-aminothiophenol (245 mg, 2 mmol); Yield:
0.21 g (46%); 1H NMR (400 MHz, DMSO-d6): d= 6.92–
6.97(m, 2H), 7.36–7.43 (m, 3H), 7.57–7.62 (m, 3H), 8.92 (s,
1H), 12.85 (s, 1H); 13C NMR (100 MHz, DMSO-d6):
d= 117.1, 119.67, 119.71, 123.0, 129.4, 133.0, 134.0, 134.4,
148.2, 160.7, 164.3.
2.1.18. (E)-4-(2-Hydroxybenzylideneamino)benzamide (18)
Compound 18 was prepared from salicylaldehyde (1.22 g,
10 mmol) and 4-aminobenzamide (1.22 g, 9 mmol); Yield:
0.89 g (41%); 1H NMR (400 MHz, DMSO-d6): d= 6.94–
6.99 (m, 2H), 7.38–7.46 (m, 4H), 7.66 (dd, JAB = 7.2 Hz,
JAX = 1.6 Hz, 1H), 7.93–7.96 (m, 2H), 8.01 (s br, 1H), 8.98
(s, 1H), 12.85 (s br, 1H); 13C NMR (100 MHz, DMSO-d6):
d= 113.0, 117.1, 119.7, 121.4, 121.6, 129.4, 129.6, 132.8,
133.1, 134.0, 151.0, 152.1, 160.8, 164.9, 167.9, 168.7.
2.2. Biological activity
All the compounds were screened for their in vitro antimicrobial
activity according to the disc diffusion method (Bauer et al.,
1966). The assay was determined against gram negative bacteria
including Escherichia coli (E. coli), Proteus mirabilis (P. mirabi-
lis), Pseudomonas aeruginosa (P. aeruginosa) and Serratia mar-
cescens (S. marcescens), gram positive bacteria including
Staphylococcus epidermidis (S. epidermidis);Staphylococcus aur-
eus (S. aureus) andBacillus subtilis (B. subtilis), and fungi includ-
ing Alternaria alternata (A. alternata), Aspergillus niger (A.
niger), Penicillium italicum (P. italicum), Penicillium roqueforti
(P. roqueforti), and Saccharomyces cerevisiae (S. cerevisiae).
Sterile 6 mm-diameter sensitivity discs were impregnated with
different concentrations (100, 200 and 400 lg/mL) of the synthe-
sized compounds dissolved in DMSO. Each concentration was
prepared in four replicates. Data in the results came only from
400 lg/mL, unless otherwise stated. Discs of each tested
compound were laid onto nutrient agar for bacteria or potatodextrose agar (PDA) for fungi. The plates were then incubated
for 24 h at 37 C for bacteria and for 72 h at 28 C for fungi. Sim-
ilar discs for the positive antibacterial and antifungal controls,
Ampicilin (100 lg/disc; Sigma, St. Louis, USA) and Cyclohexi-
mide (50 lg/disc; Sigma, St. Louis, USA), respectively, were
prepared (Al-Omar, 2010; Elnakeeb et al., 1965). The results
were recorded by measuring the zones of growth inhibition sur-
rounding the discs. The mean value obtained of three indepen-
dent replicates was used to calculate the zone of growth
inhibition of each sample. The compound activities at a concen-
tration of 100 lg/disc are presented in Tables 1 and 2.
2.3. Optical titration experiment
Binding strength of a given Schiff base with Salmon DNA was
monitored by the common UV–vis spectrophotometric titra-
tion method (Saleh et al., 2011), which reﬂects the stability
of the studied DNA-chelating complex. In the titration exper-
iment, the total concentration of the free Schiff base (ligand)
was kept constant and that of DNA was gradually increased.
The absorption spectra were then recorded for a given Schiff
base in ethylene glycol solvent as a function of DNA concen-
tration under ambient temperature. The variation in the absor-
bance at a selected wavelength (chosen so that the changes are
as large as possible) was then analysed to obtain the stability
constants (K) of the complexes using a nonlinear formula in
the Sigma Plot software (version 6.1, SPCC, Inc., Chicago, Illi-
nois, USA), which we have previously reported (Saleh et al.,
2011). The molar extinction coefﬁcients of the complex were
left as a ﬂoating parameter in the analysis by Levenberg–Mar-
quardt algorithm provided by the software itself.
3. Results and discussion
The antibiotic activity within a particular class of compounds
is often modulated by subtle changes within its core structure.
Naphthyl rings were introduced in Schiff bases 9, 10 and 11 to
investigate the effect of steric bulk while the basicity of the
imine nitrogen in 2 and 3 was controlled by electron-withdraw-
ing halogens in the para position of the aromatic amine precur-
sor. In addition, hydrogen bonding in a host–guest interaction
is usually crucial in determining the biological activity of
drugs. Therefore, we prepared and investigated Schiff bases
possessing hydrogen donors capable of intramolecular (6, 14,
15) and intermolecular (4, 5, 16, 17, and 18) hydrogen bonding.
The effect of hydrogen bond acceptors was also examined in
compounds 8, 12, and 13.
To investigate the antimicrobial effect of the salicylidinani-
line and naphthylidene compounds, we tested all synthesized
compounds (Fig. 1) for their in vitro antimicrobial activity
against a panel of standard strains of the Gram-positive bacte-
ria: S. epidermidis, S. aureus and B. subtilis; the Gram-negative
bacteria: E. coli, P. mirabilis, P. aeruginosa and S. marcescens;
and the pathogenic fungi: A. alternata, A. niger, P. italicum
and S. cerevisiae. The primary screening was carried out using
the agar disc-diffusion method (Bauer et al., 1966). The diam-
eter of the growth inhibition zones was measured after 24 h in
bacteria and 72 h in fungi. The results of the antibacterial test-
ing of compounds (400 lg/mL) and their corresponding antibi-
otic Ampicillin (100 lg/disc) are shown in Table 1; whereas the
antifungal testing and the corresponding antibiotic drug
Table 1 Antibacterial activity of the synthesized Schiff base compounds 1–18a.
Zone of inhibition in mmb
Compound Substituents on the
aryl amine site
Gram negative bacteria Gram positive bacteria
E. coli P. mirabilis P. aeruginosa S. marcescens S. epidermidis S. aureus B. subtilis
1 H – – – – 12 – –
2 Cl 7 – 9 9 – – –
3 Br – – – – – – –
4 SO2NH2 – – – NT – – –
5 CO2H – 10 – – – 15 –
6 OH (othro) 7 8 – – – – 16
7 CH3 – – – – – – –
8 CH3 – – – – – – –
9 – – – – – – –
10 – – – – – – –
11 – – – – – – –
12 – – – – – – 17
13 – – – – 14 – –
14 SH (ortho) – 3 9 11 8 9 11
15 CO2H (ortho) – – – – – – –
16 CONH2 – – – NT – – –
17 SH – – – NT 5 – –
18 OH 10 5 – NT 6 – 15
Ampicilin
(100 lg/disc) 16 14 15 4 19 18 18
–, not active; NT, not tested.
a The concentration of test compounds was (400 lg/mL). Solvent used DMSO.
b Mean value (SEM).
Table 2 Antifungal activity of the synthesized compounds 1–18a.
Zone of inhibition in mmb
Compound Substituents on the aryl amine site Fungi
A. alternata A. niger P. roqueforti S. cerevisiae
1 H 8 11 – 9
2 Cl 10 – – –
3 Br – – – –
4 SO2NH2 4 – – –
5 CO2H 9 – – –
6 OH (othro) 9 – – –
7 CH3 – – – –
8 CH3 – – – –
9 9 – 9 –
10 – – 9 –
11 – – – –
12 – – – 11
13 – – – –
14 SH (ortho) 8 12 8 12
15 CO2H (ortho) 10 – – –
16 CONH2 – – 4 –
17 SH 5 – 5 –
18 OH 11 18 19 17
Cycloheximide (50 lg/disc) 17 16 14 19
–, not active; NT, not tested.
a The concentration of test compounds was (400 lg/mL). Solvent used DMSO.
b Mean value (SEM).
Antipathogenic effects of structurally-related Schiff base derivatives: Structure–activity relationship 833cycloheximide (50 lg/disc) are shown in Table 2. In case the
inhibition diameter exceeds 14 mm, the compound has strong
antimicrobial activity; between 8 and 13 mm it is moderate;
whereas less than 7 mm inhibition zone, it is considered weak.The results revealed that the synthesized compounds showed
varying degrees of inhibition against the tested microbes. In
general, the best activity was displayed by compounds 14
and 18 (Table 1), since they showed potential antimicrobial
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Figure 2 Binding spectrophotometric titrations of Schiff base 14 (70 lM) with DNA (Salmon tests) up to 2 mg/ml in a water–ethylene
glycol (1:1, v/v) mixture at room temperature by (A) UV–visible and (B) ﬂuorescence. No changes in the optical spectral proﬁle. The inset
shows the nonlinear ﬁtting of the emission data according to a 1:1 complexation model; K= 0.39 ± 2.66 · (Molar mass of DNA) M1
(R= 0.99), which is very weak and contains large error!
834 S. Hisaindee et al.activity against almost all bacterial pathogens tested. Previous
reports supported our data of antibacterial activity of Schiff
bases structured with either hydroxyl (–OH; compound 14)
or sulfhydryl (–SH; compound 18) group. In these studies,
not only the aromatic –OH group in curcumin analogues
showed an inhibitory effect, but also a combination of a Schiff
base with the sulphide/disulphide bond in the acyl side chain
had moderate activities against some pathogenic bacteria (Al-
wan, 2012; Amin et al., 2010; Kim et al., 2012a,b; Ronad et al.,
2010; Vukovic et al., 2010).
The Gram positive bacteria S. epidermidis and B. subtilis
are considered the most sensitive among the bacteria tested
on the eighteen Schiff base derivatives (Table 1). Compound
13 was selectively active (inhibition zone > 14 mm) against
S. epidermidis, compound 5 against S. aureus, and compounds
6, 12 and 18 against B. subtilis. Thus, none of the Gram-neg-
ative bacteria showed a strong inhibition zone towards any
of the tested compounds (Table 1). Moderate or weak activity
towards all Gram-negative bacteria was observed for com-
pounds 2, 5, 6, 14, and 18. Meanwhile, compounds 3, 4, 7, 8,
9, 10, 11, 15, and 16 were inactive against the tested bacteria.
These results suggest that some of the synthesized salicylid-inanilines are only active against Gram-positive pathogenic
bacteria.
Schiff bases bearing the ortho sulfhydryl group (i.e. com-
pounds 14) or para hydroxyl group on aniline site (i.e. com-
pound 18) had moderate-strong inhibitory activity to all
fungal strains; yet compound 18 is the most active (Table 2).
Schiff bases carrying these crucial groups showed antioxidant
activity (Vukovic et al., 2010), which may inﬂuence the fungal
cell permeability via interference with the synthesis of cellular
walls, deactivation of different cellular enzymes, denaturation
of one (or more) cellular proteins, or formation of a H-bond
between the these groups and the target component of the cel-
lular structure, which may ultimately interfere with the fungal
growth or cell death (Cacic et al., 2010). Interestingly, Fig. 2
demonstrated the lack of binding between derivative 14 and
the DNA, which might suggest that the interaction with cellu-
lar membrane or proteins, not with DNA, is what rationalizes
the trend in the corresponding biological data.
Among all tested microorganisms, the fungus, A. alternata,
is the most sensitive (Table 2). Except compounds 1, 14 and 18,
the rest of the synthesized compounds were practically inactive
against A. niger. Compounds 4, 16 and 17 produced either no
Antipathogenic effects of structurally-related Schiff base derivatives: Structure–activity relationship 835or weak activity relative to the antifungal drug cycloheximide
or any other synthesized compounds (Table 2). While, the fun-
gal pathogen, A. alternata, is susceptible to most of the synthe-
sized drugs, none of the fungal pathogens grew on compound
3, 7, 8, 11, or 13. In general, the examined Schiff base deriva-
tives, showing an antifungal activity belong to either moderate
or strong antipathogenicity, suggesting a potential use of these
synthesized drugs against fungal pathogens. Overall, our data
demonstrate high broad-spectrum inhibitory activity of Schiff
base compounds containing hydroxyl and/or sulfhydryl groups
against microorganisms (Tables 1 and 2) and cancer (personal
communication, R.I.).
It is also interesting to compare our ﬁndings with previ-
ously published data by other research groups on our selected
compounds, namely compounds 4 (Kumar et al., 2010), 6 (Ab-
del Aziz et al., 2012), and 7 (Al-Kahraman et al., 2010). Com-
pound 4 (200 lg/ml) was tested by (Kumar et al., 2010) against
B. subtilis, S. aureus, E. coli, and A. niger and the result indi-
cated moderate inhibitory action in contrast to our ﬁndings
(Table 1). Compound 6 was examined by (Abdel Aziz et al.,
2012) against two bacterial strains E. coli and S. aureus (Ta-
ble 1). Their results showed higher inhibitory growth effects
when compared to our data (Table 1; viz. 13 versus 7 for
E. coli and 13 versus nothing for S. aureus. This might be ex-
plained by the higher concentration that they had used (20 mg/
ml versus 400 lg/ml). Compound 7 was tested by Yasinazi and
his research group (Al-Kahraman et al., 2010) against different
types of fungi to what we have tested, yet on four types of bac-
teria that were also studied by us in Table 1 (E. coli, P. aeru-
ginosa, B. subtilis, and S. aureus) using relatively similar
concentration (1 mg/ml for the antibacterial activity and
200 mg/ml for the antifungal activity), and their results sup-
ported lack of activity for this derivative in particular [6]. Putt-
ing together, the present work constitutes a comprehensive
investigation of what appears to be of renewed interest in the
medicinal ﬁelds for such type of drugs.
4. Conclusion
In summary, having a series of Schiff base derivatives that
share common structural properties and by considering their
antibacterial and antifungal effects, it was possible to rational-
ize the trend in the biological data on the basis of speciﬁc struc-
tural properties of the examined drugs. Generally speaking,
drugs with –OH and –SH group tend to be mostly active than
otherwise substituted, depending on their position on Schiff
base backbone structures. Thus, the present ﬁndings are useful
in advancing the efforts towards achieving a systematic predic-
tion of the absolute biological effects in a rational way. Such
information is currently in high demand to the biological
and medicinal communities.Acknowledgements
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